Biotech firms hit as cash dries up and research shifts eastward
Monday 08 November 2010
The global biotechnology business model is "breaking down" as investors tighten purse strings and the industry's research base shifts to emerging economies, a report suggests.
Last year, biotech companies in Europe managed to raise just $1.1bn (£678m) in venture capital – the lowest haul since 2003. The auguries are also dim: 84 per cent of the participants at a recent biopharmaceutical conference in Monaco view funding as the industry's prime challenge.
Historically, the biotech industry has relied on external investment to develop innovative ideas that have often sprung from the world of academia. Investors dug into their pockets in the hope of cashing in by floating biotech firms or selling new therapies to established players in the pharmaceuticals sector.
But the business model is risky and many investments end up in the red. A report by the accountant PricewaterhouseCoopers cites a recent study of 1,606 biotech investments realised between 1986 and 2008. Of these, 704 resulted in a full or partial loss and 16 managed only to cover their costs.
The gross rate of return on these investments stood at nearly 26 per cent, well above the pooled average return of 17 per cent on all venture capital invested over the period. But the net rate of return was less than 16 per cent when costs and the impact of unrealised investments were factored in to the figures.
PwC said that while biotechnology companies had produced some valuable medical treatments, they had failed to reduce the risks inherent in the discovery and development of new drugs. "Biotech companies don't develop new medicines much more quickly or economically than pharma companies do," says the report, which is published today.
Moreover, it adds that many of the external conditions that supported the industry's success stories are "rapidly vanishing". One the one hand, investors who have been battered by the recent economic slump have become more cautious. On the other, the research base is shifting, with emerging economies competing more aggressively.
Between 1998 and 2006, for example, the number of students graduating with doctorates in the physical and biological sciences grew by 43 per cent in India. China was even further ahead, with 222 per cent growth. Besides rising numbers of doctoral students, both India and China have benefited from the return of about 100,000 of their highly-skilled expatriates from the US. Another 100,000 are expected to follow in the next five years.
These trends are supplemented by local investment. China has pumped $9.2bn into technological research and development, including biotech, in the past 18 months, while India is looking at plans to become one of the world's five producers of biosimilars (cheap copies of biotech medicines) by 2020.
- 1 Forget 'The Dress': Here are five of the biggest news stories you might have missed
- 2 The black and blue dress: Makers considering a white and gold version
- 3 Prince Harry leaving the armed forced to pursue conservation projects in Africa
- 4 PornHub turns masturbation into energy in bid to save the planet
- 5 The remarkable archaeological underwater discovery that could open up a new chapter in the study of European and British prehistory
Boris Nemtsov shot dead: Outspoken Putin critic who had expressed fears for his life is killed near the Kremlin
Leonard Nimoy dead: Star Trek Spock actor dies after suffering lung disease
PornHub turns masturbation into energy in bid to save the planet
Ukraine crisis: Top Chinese diplomat backs Putin, says West should 'abandon zero-sum mentality'
White and gold or blue and black – what colour is the dress? An eyewitness gives a definitive answer
New theory could prove how life began and disprove God
Half of Ukip voters say they are prejudiced against people of other races
'Cash for access' scandal: Sir Malcolm Rifkind says 'unrealistic' for MPs to live on £67,000 salary
This is what it's like to be dead, according to a guy who died for a bit
'Jihadi John': CAGE representative storms off Sky News accusing Kay Burley of Islamophobia
Aqsa Mahmood branded a 'disgrace' by her parents after claims she recruited three UK girls flying to Middle East
iJobs Money & Business
£40000 - £50000 per annum + pro rata: SThree: SThree Group have been well esta...
£30000 - £37000 per annum: Recruitment Genius: Established in 1999, a highly r...
£250-£300 Day Rate: Jemma Gent: Are you a qualified accountant with strong exp...
£230 - £260 Day Rate: Jemma Gent: Do you want to stamp your footprint in histo...